Recombinant 53 kDa major outer membrane protein

Shipped with Ice Packs
In Stock

Description

Membrane Permeability and Porin Activity

The 53 kDa OMP functions as a porin, facilitating diffusion of small molecules across the outer membrane. In T. denticola, the MOSP C-terminal domain forms trimeric channels, enabling nutrient uptake and waste expulsion .

Immune Evasion and Cross-Reactivity

  • Host Antibody Interaction: The 53 kDa protein binds to CT antibody, suggesting antigenic conservation across Campylobacter species .

  • Vaccine Potential: Recombinant PorA (53 kDa OMP) is explored as a vaccine candidate due to its immunogenicity and cross-reactivity .

Production Methods

Recombinant 53 kDa OMPs are typically expressed in E. coli or yeast systems using:

  1. Sarkosyl Purification: Isolates outer membrane complexes (OMCs) for protein extraction .

  2. Cloning and Sequencing: PCR amplification of porA genes followed by heterologous expression .

Experimental Uses

ApplicationMethodologyOutcomeReferences
ImmunoblottingCT antibody detects 53 kDa bands in crude/purified OMPsConfirms cross-reactivity in Campylobacter
Antigenic MappingMonospecific antibodies target recombinant 53 kDa OMPsIdentifies surface-exposed epitopes
Vaccine DevelopmentRecombinant PorA tested in murine models for immune responseElicits antibodies against C. jejuni

Comparative Analysis Across Species

SpeciesProtein NameMolecular WeightKey Distinctions
C. jejuniPorA53 kDaDominant OMP, cross-reacts with CT antibody
C. fetusS-layer OMPLadder-like bandsUnique S-layer structure
T. denticolaMOSP53 kDaPorin activity, periplasmic conformers
C. pneumoniaeOmp4/Omp597–99 kDaDistant homologs, surface-exposed epitopes

Challenges and Future Directions

  • Antigenic Variability: While PorA is conserved in Campylobacter, C. fetus exhibits unique S-layer proteins, complicating vaccine design .

  • Diagnostic Tools: Recombinant 53 kDa OMPs could improve serodiagnostic assays for Campylobacter infections, though cross-reactivity with non-pathogenic species requires validation .

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but special format requests can be made during ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specifics. Proteins are shipped with blue ice packs by default; dry ice shipping requires prior arrangement and incurs extra fees.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Specify your preferred tag type, and we will prioritize its development.
Synonyms
mfa1; Minor fimbrium subunit Mfa1; 53 kDa major outer membrane protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-25
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Porphyromonas gingivalis
Target Names
mfa1
Target Protein Sequence
AGDNDYNPIG EYGGVDKIND LTVYV
Uniprot No.

Target Background

Function
Mfa1 is a structural subunit of minor fimbriae, which are surface-attached filaments mediating biofilm formation, adhesion to host cells and other oral bacteria. These fimbriae are vital for periodontal tissue invasion and are considered major virulence factors. Mfa1 sequence varies significantly across strains, correlating with pathogenicity.
Protein Families
Bacteroidetes fimbrillin superfamily, FimA/Mfa1 family
Subcellular Location
Fimbrium. Cell outer membrane.

Q&A

What is the 53 kDa major outer membrane protein and why is it significant in research?

The 53 kDa major outer membrane protein refers to a class of proteins found in bacterial outer membranes, particularly in Gram-negative bacteria. These proteins are significant in research due to their highly conserved nature across species and their multifunctional roles. For example, the 53 kDa protein from Trichinella spiralis (rTsP53) demonstrates remarkable immunomodulatory properties that can attenuate inflammatory conditions in experimental models .
Research has identified that 53 kDa proteins from diverse sources, including virally transformed human cell lines and chemically transformed mouse tumor cell lines, show remarkably similar amino acid compositions and sequences, suggesting they perform critical functions in various transformation systems . These proteins typically function as porins with beta-barrel structures embedded in the bacterial outer membrane, facilitating selective permeability and ion transport across the membrane .

How do native membrane environments affect the structure and function of recombinant 53 kDa proteins?

The native membrane environment significantly impacts the structure and function of 53 kDa outer membrane proteins. Studies comparing outer membrane proteins in outer membrane vesicles (OMVs) versus those reconstituted into artificial lipid membranes have revealed different unfolding pathways, highlighting the importance of the native environment .
Native membranes provide:

  • Specific lipid composition that modulates protein function

  • Natural asymmetry of lipid distribution

  • Proper lateral pressure profiles

  • Native protein-lipid interactions
    When studying these proteins, researchers should consider that reconstitution into artificial membranes may alter protein behavior. Using OMVs provides an alternative approach to study membrane proteins in their native context, allowing for more physiologically relevant observations of folding, assembly, and structure . This approach has revealed that some outer membrane proteins follow different unfolding pathways in native versus artificial environments, suggesting that structural and functional studies may yield different results depending on the membrane context chosen for experiments.

What are the optimal methods for recombinant expression of 53 kDa outer membrane proteins?

Successful recombinant expression of 53 kDa outer membrane proteins requires careful consideration of several factors:

  • Codon optimization: Analysis of 11,430 recombinant protein production experiments revealed that the accessibility of translation initiation sites (modeled using mRNA base-unpairing across Boltzmann's ensemble) significantly outperforms other features in predicting expression success . Tools like TIsigner can be used to optimize the first nine codons with synonymous substitutions to enhance expression.

  • Translation initiation site considerations: The region spanning −24:24 nucleotides relative to the start codon shows the highest correlation with successful expression, suggesting this region's accessibility is crucial for efficient translation initiation .

  • Host selection: Escherichia coli remains a common expression system due to its simplicity and high yield, but the native cellular context should be considered if structural integrity is paramount .

  • Membrane environment preservation: For structural and functional studies, expressing the protein in systems that generate outer membrane vesicles (OMVs) can maintain the native membrane environment, preserving protein structure and function better than detergent solubilization or artificial membrane reconstitution .
    For optimal results, researchers should focus on maximizing mRNA accessibility at translation initiation sites rather than solely optimizing based on traditional metrics like codon adaptation index (CAI) or minimum free energy (MFE) calculations .

How can recombinant 53 kDa proteins be utilized in inflammatory disease research?

Recombinant 53 kDa proteins, particularly from parasitic sources like Trichinella spiralis (rTsP53), show significant potential in inflammatory disease research through their immunomodulatory properties:

  • Inflammatory Bowel Disease (IBD) models: In TNBS-induced colitis models, subcutaneous administration of 50 μg rTsP53 (three doses at 5-day intervals) significantly reduced disease activity index, macroscopic and microscopic scores . The protein decreases pro-inflammatory Th1 cytokines (TNF-α, IFN-γ) while elevating Th2 cytokines (IL-4, IL-13) .

  • Sepsis-induced myocardial dysfunction: In septic mice models (induced by cecal ligation puncture), rTsP53 treatment decreased mortality and reduced cardiac activation of NF-κB and expression of inflammatory cytokines (TNF-α, IL-6, IL-1β) . Significantly, it improved myocardial contractility parameters, including increased ejection fraction and end-systolic elastance .

  • Macrophage polarization: rTsP53 increases colonic M2 macrophage markers (arginase-1, FIZZ1), suggesting it promotes alternatively activated macrophages that contribute to anti-inflammatory responses .
    Experimental design should include appropriate controls and dosing regimens. The predominant detection of IgG1 (but not IgG2a) in treated animals indicates that rTsP53 triggers a highly polarized Th2-type immune response, which appears central to its therapeutic mechanism .

What structural analysis techniques provide the most accurate characterization of recombinant 53 kDa outer membrane proteins?

Comprehensive structural characterization of recombinant 53 kDa outer membrane proteins requires complementary techniques that provide insights at different resolution levels:

  • Native membrane-preserving approaches:

    • Outer membrane vesicles (OMVs) provide an excellent platform for studying these proteins in their native membrane environment

    • Cryo-electron microscopy of OMVs allows visualization of proteins in their native context without artificial membrane reconstitution

  • Beta-barrel topology determination:

    • Since many outer membrane proteins, including the 53 kDa major outer membrane protein, are porins with beta-barrel structures , techniques that elucidate this topology are crucial

    • Circular dichroism spectroscopy to determine secondary structure content

    • Hydrogen-deuterium exchange mass spectrometry to identify solvent-exposed regions

    • Targeted disulfide cross-linking to confirm predicted structural arrangements

  • Functional characterization:

    • Channel conductance measurements in native versus artificial membranes

    • Ion selectivity determination through electrophysiological methods

    • Ligand binding assays for proteins with transport functions
      The choice of method should consider that these proteins often exhibit different unfolding pathways in native versus artificial membrane environments . For the most accurate results, researchers should prioritize approaches that maintain the native membrane context or compare results across multiple membrane environments to identify potential artifacts.

How do synonymous codon changes impact the expression of recombinant 53 kDa outer membrane proteins?

Synonymous codon optimization significantly impacts recombinant protein expression, with specific relevance to 53 kDa outer membrane proteins:

  • Translation initiation site accessibility: Analysis of 11,430 recombinant protein production experiments revealed that the accessibility of translation initiation sites is the single best predictor of expression success, outperforming traditional metrics like codon adaptation index (CAI) .

  • Critical region for optimization: The region spanning −24:24 nucleotides relative to the start codon shows the highest correlation with successful expression . This region encompasses both the Shine-Dalgarno sequence and the early coding sequence.

  • Minimal necessary modifications: As few as nine synonymous codon changes at the beginning of the coding sequence can dramatically alter expression levels through modifying mRNA secondary structure accessibility .

  • Optimization approach:

    • Tools like TIsigner, which uses simulated annealing to modify the first nine codons with synonymous substitutions, can be employed

    • Focus on increasing accessibility rather than optimizing metrics like GC content

    • Higher accessibility generally leads to higher protein production, though potentially at the cost of slower cell growth
      When expressing complex outer membrane proteins, researchers should prioritize translation initiation site accessibility over traditional codon optimization approaches focused solely on tRNA abundance or GC content optimization .

What experimental considerations are essential when assessing the immunomodulatory properties of recombinant 53 kDa proteins?

When investigating the immunomodulatory effects of recombinant 53 kDa proteins such as rTsP53, researchers should implement the following methodological considerations:

  • Dosing protocols:

    • Standard effective dose: 50 μg rTsP53 administered subcutaneously

    • Administration schedule: Three doses at 5-day intervals for colitis models or two-week intervals for sepsis models

    • Route considerations: Subcutaneous administration has shown efficacy, but route comparison studies may be valuable

  • Immunological assessment:

    • Antibody isotype profiling: Measure specific IgG1 and IgG2a to determine Th1/Th2 polarization (rTsP53 typically induces predominantly IgG1, indicating Th2 bias)

    • Cytokine profiling: Measure both serum and tissue-specific cytokines

      • Serum: TNF-α, IFN-γ, IL-4, IL-13

      • Tissue-specific: TNF-α, IL-6, IL-10, TGF-β1

  • Macrophage polarization analysis:

    • M2 marker assessment: Arginase-1 (Arg-1) and Found in Inflammatory Zone 1 (FIZZ1)

    • Functional assessment of macrophages isolated from treated animals

  • Disease-specific parameters:

    • For colitis models: Disease Activity Index (DAI), macroscopic and microscopic scoring systems

    • For sepsis models: Mortality rates, cardiac function (ejection fraction, end-systolic elastance), NF-κB pathway activation

  • Control considerations:

    • Empty vector controls for recombinant protein studies

    • Heat-inactivated protein controls to confirm structure-dependent effects

    • Timing control groups to assess prophylactic versus therapeutic administration
      The experimental design should include appropriate time points for sampling, as cytokine profiles may vary significantly during the course of inflammatory response.

What are the major challenges in maintaining native conformation of recombinant 53 kDa outer membrane proteins?

Maintaining the native conformation of recombinant 53 kDa outer membrane proteins presents several significant challenges:

  • Membrane environment dependence:

    • Outer membrane proteins exhibit different unfolding pathways in native versus artificial membrane environments

    • The specific lipid composition of native membranes modulates protein functional states

    • Solution: Utilize outer membrane vesicles (OMVs) as a platform to study these proteins in their native environment

  • Beta-barrel structural integrity:

    • Many outer membrane proteins, including 53 kDa proteins, have beta-barrel structures with tight β-turns extending into the periplasmic space and flexible loops reaching beyond the extracellular surface

    • Solution: Consider expression systems that facilitate proper insertion into membranes, including specialized chaperones for beta-barrel assembly

  • Post-translational modifications:

    • Native modifications may be absent in heterologous expression systems

    • Solution: Consider expression in systems closer to the native host or engineer in vitro modification capabilities

  • Aggregation during overexpression:

    • High expression levels may lead to protein misfolding and aggregation

    • Solution: Lower induction temperatures, use solubility-enhancing tags, or optimize translation initiation site accessibility to fine-tune expression levels

  • Purification-induced denaturation:

    • Detergents used in purification may disrupt native structure

    • Solution: Use milder detergents or detergent-free methods such as styrene-maleic acid lipid particles (SMALPs) for extraction while maintaining the native lipid environment
      The most promising approach for structural and functional studies is using OMVs, which maintain the native membrane environment while enabling various analytical techniques .

How can outer membrane vesicles (OMVs) be optimized for studying recombinant 53 kDa outer membrane proteins?

Outer membrane vesicles (OMVs) provide an excellent native platform for studying recombinant 53 kDa outer membrane proteins. Here's how to optimize their use:

  • Protein enrichment strategies:

    • Engineer bacterial strains to overexpress the target protein in the outer membrane

    • Utilize protein ligation techniques to display recombinant proteins on OMVs

    • Consider hypervesiculating mutants to increase OMV yield while maintaining native membrane properties

  • OMV isolation and purification:

    • Ultra-centrifugation techniques with density gradients to separate OMVs from cellular debris

    • Size-exclusion chromatography for additional purification

    • Quality control using nanoparticle tracking analysis and electron microscopy

  • Analytical considerations:

    • For structural studies: Compare Omps in OMVs to those reconstituted into artificial lipid membranes to identify potential differences in unfolding pathways

    • For functional studies: Develop assays that can be performed with intact OMVs rather than requiring protein extraction

  • Experimental controls:

    • Generate OMVs from bacteria that do not express the protein of interest (negative control)

    • Compare results with conventional reconstitution approaches to identify environment-dependent characteristics

  • Advanced applications:

    • Use OMVs to study protein-protein interactions in the native membrane context

    • Employ OMVs for immunological studies, as they present antigens in their native conformation
      This approach allows researchers to study the assembly, folding, and structure of outer membrane proteins in their native membrane environment, providing insights that may be missed when using conventional solubilization or reconstitution methods .

What strategies can resolve expression difficulties for recombinant 53 kDa outer membrane proteins?

When facing challenges in expressing recombinant 53 kDa outer membrane proteins, researchers can implement several evidence-based strategies:

  • Optimize translation initiation:

    • Focus on the accessibility of translation initiation sites rather than traditional codon optimization metrics

    • Modify the region spanning −24:24 nucleotides relative to the start codon, which shows the highest correlation with successful expression

    • Use tools like TIsigner that optimize the first nine codons with synonymous substitutions to enhance expression

  • Expression system selection:

    • For structural and functional studies: E. coli-based systems that facilitate OMV production

    • For high yield: Consider specialized strains with enhanced membrane protein expression capabilities

    • For specific post-translational modifications: Select systems that can perform required modifications

  • Induction conditions:

    • Lower induction temperatures (16-25°C) to slow folding and membrane insertion

    • Extended induction times with lower inducer concentrations

    • Consider auto-induction media for gradual protein production

  • Fusion partners and tags:

    • N-terminal fusion partners that enhance translation initiation

    • Signal sequences optimized for outer membrane targeting

    • Solubility-enhancing tags that can be removed after expression

  • Troubleshooting expression failures:

    • Analyze mRNA levels to determine if the issue is transcriptional or translational

    • Examine accessibility across the Boltzmann's ensemble of mRNA conformations

    • Consider protein toxicity effects on host cells and implement tightly controlled expression systems
      Data from large-scale expression studies indicate that approximately 50% of recombinant proteins fail to be expressed in various host cells . By systematically addressing translation initiation site accessibility, researchers can significantly improve success rates, particularly for challenging membrane proteins.

How might high-throughput approaches advance the understanding of structure-function relationships in 53 kDa outer membrane proteins?

High-throughput approaches offer promising avenues for elucidating structure-function relationships in 53 kDa outer membrane proteins:

  • Systematic mutagenesis and phenotyping:

    • Create comprehensive libraries of point mutations across the protein sequence

    • Couple with functional assays to identify critical residues for various functions

    • Map results onto structural models to identify functional domains

  • AI-assisted protein design:

    • Utilize machine learning approaches trained on the extensive dataset of 11,430 recombinant protein production experiments

    • Develop predictive models for expression optimization beyond translation initiation sites

    • Generate novel variants with enhanced stability or function

  • Cryo-EM structural analysis:

    • Apply high-throughput cryo-EM approaches to multiple protein variants simultaneously

    • Compare structures in different membrane environments to identify environment-dependent conformational changes

    • Integrate with computational modeling for complete structural understanding

  • Multi-omics integration:

    • Combine proteomics, transcriptomics, and metabolomics data to understand the systemic impact of these proteins

    • Identify interaction networks in native versus heterologous expression systems

  • Therapeutic screening platforms:

    • Develop high-throughput screening approaches to identify compounds that modulate 53 kDa protein function

    • Utilize the immunomodulatory properties of proteins like rTsP53 as a foundation for novel therapeutic development
      These approaches will help bridge the gap between the evolutionary conservation of these proteins and their diverse functional roles across different organisms and disease states.

What is the potential for therapeutic applications of recombinant 53 kDa proteins in inflammatory conditions?

Recombinant 53 kDa proteins, particularly those derived from parasitic organisms like Trichinella spiralis, demonstrate significant therapeutic potential for inflammatory conditions:

  • Inflammatory bowel disease (IBD):

    • rTsP53 significantly ameliorates disease activity index and histological damage in experimental colitis

    • Mechanism involves decreasing serum Th1 cytokines (TNF-α, IFN-γ) while elevating Th2 cytokines (IL-4, IL-13)

    • Potential for local delivery systems to target intestinal inflammation specifically

  • Sepsis-induced organ dysfunction:

    • rTsP53 reduces mortality in septic mice and improves myocardial function

    • Attenuates cardiac activation of NF-κB and expression of inflammatory cytokines (TNF-α, IL-6, IL-1β)

    • Could be developed as an adjunctive therapy to conventional sepsis management

  • Macrophage reprogramming applications:

    • Increases markers of alternatively activated macrophages (M2): arginase-1 (Arg-1) and Found in Inflammatory Zone 1 (FIZZ1)

    • Potential for treating conditions where macrophage polarization plays a key role (atherosclerosis, metabolic disorders)

  • Delivery system development:

    • Encapsulation in nanoparticles for targeted delivery

    • Incorporation into hydrogels for sustained release

    • Design of synthetic analogues based on the active domains of these proteins

  • Combination therapy approaches:

    • Synergistic effects with conventional anti-inflammatory agents

    • Sequential therapy protocols to induce remission and maintain response
      These therapeutic applications are supported by the consistent immunomodulatory effects observed across different disease models , suggesting a fundamental mechanism that could be harnessed for various inflammatory conditions.

How do post-translational modifications affect the function of recombinant 53 kDa outer membrane proteins?

Post-translational modifications (PTMs) can significantly impact the structure, function, and immunogenicity of recombinant 53 kDa outer membrane proteins. While specific PTM data for these proteins is limited in the provided search results, general principles and research considerations include:

  • Glycosylation considerations:

    • Bacterial outer membrane proteins may contain sugar modifications that affect folding and stability

    • Expression in E. coli typically lacks glycosylation machinery, potentially affecting protein properties

    • Research approach: Compare native and recombinant proteins using glycan-specific staining or mass spectrometry to identify differences

  • Lipid modifications:

    • Lipoproteins in the outer membrane require proper lipidation for membrane anchoring

    • Incomplete lipid modification may affect membrane insertion and protein function

    • Research approach: Use radiolabeled lipid precursors to track modification efficiency in different expression systems

  • Disulfide bond formation:

    • Proper disulfide bonding is critical for maintaining the tertiary structure of many outer membrane proteins

    • Recombinant expression may result in incorrect disulfide patterns

    • Research approach: Use mass spectrometry to map disulfide bonds and compare with predicted models

  • Proteolytic processing:

    • Signal sequence cleavage must occur correctly for proper membrane insertion

    • Additional proteolytic events may be required for maturation

    • Research approach: N-terminal sequencing to confirm proper processing

  • Impact on immunomodulatory function:

    • For proteins like rTsP53, modifications may affect immunological properties

    • Altered glycosylation patterns could change recognition by pattern recognition receptors

    • Research approach: Compare immunological responses to native versus recombinant proteins with different modification patterns
      Understanding these modifications is essential for producing functionally equivalent recombinant proteins and may provide insights into the evolutionary conservation observed across different species .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.